| The split personality of regulatory T cells in HIV infection MF Chevalier, L Weiss Blood, The Journal of the American Society of Hematology 121 (1), 29-37, 2013 | 283 | 2013 |
| HIV-1-Specific Interleukin-21+ CD4+ T Cell Responses Contribute to Durable Viral Control through the Modulation of HIV-Specific CD8+ T Cell Function MF Chevalier, B Jülg, A Pyo, M Flanders, S Ranasinghe, DZ Soghoian, ... Journal of virology 85 (2), 733-741, 2011 | 250 | 2011 |
| Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis S Trabanelli, MF Chevalier, A Martinez-Usatorre, A Gomez-Cadena, ... Nature communications 8 (1), 593, 2017 | 213 | 2017 |
| ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence MF Chevalier, S Trabanelli, J Racle, B Salomé, V Cesson, D Gharbi, ... The Journal of clinical investigation 127 (8), 2916-2929, 2017 | 208 | 2017 |
| The multifaceted immune regulation of bladder cancer AK Schneider, MF Chevalier, L Derré Nature Reviews Urology 16 (10), 613-630, 2019 | 161 | 2019 |
| The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation MF Chevalier, G Petitjean, C Dunyach-Remy, C Didier, PM Girard, ... PLoS pathogens 9 (6), e1003453, 2013 | 133 | 2013 |
| Double positive CD4+ CD8+ T cells are enriched in urological cancers and favor T helper-2 polarization P Bohner, MF Chevalier, V Cesson, SC Rodrigues-Dias, F Dartiguenave, ... Frontiers in immunology 10, 622, 2019 | 91 | 2019 |
| Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection G Petitjean, MF Chevalier, F Tibaoui, C Didier, ME Manea, AS Liovat, ... Aids 26 (2), 139-148, 2012 | 77 | 2012 |
| Conventional and PD-L1-expressing regulatory T cells are enriched during BCG therapy and may limit its efficacy MF Chevalier, AK Schneider, V Cesson, F Dartiguenave, I Lucca, ... European urology 74 (5), 540-544, 2018 | 67 | 2018 |
| Phenotype Alterations in Regulatory T-Cell Subsets in Primary HIV Infection and Identification of Tr1-like Cells as the Main Interleukin 10–Producing CD4+ T Cells MF Chevalier, C Didier, G Petitjean, M Karmochkine, PM Girard, ... The Journal of infectious diseases 211 (5), 769-779, 2015 | 45 | 2015 |
| Immune landscape after allo-HSCT: TIGIT-and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse V Gournay, N Vallet, V Peux, K Vera, J Bordenave, M Lambert, A Corneau, ... Blood, The Journal of the American Society of Hematology 140 (11), 1305-1321, 2022 | 42 | 2022 |
| Epithelial adhesion molecules can inhibit HIV-1–specific CD8+ T-cell functions H Streeck, DS Kwon, A Pyo, M Flanders, MF Chevalier, K Law, B Jülg, ... Blood, The Journal of the American Society of Hematology 117 (19), 5112-5122, 2011 | 39 | 2011 |
| Intravesical Ty21a vaccine promotes dendritic cells and T cell–mediated tumor regression in the MB49 bladder cancer model S Domingos-Pereira, K Sathiyanadan, S La Rosa, L Polák, MF Chevalier, ... Cancer immunology research 7 (4), 621-629, 2019 | 30 | 2019 |
| The pro-and anti-tumor role of ILC2s S Trabanelli, MF Chevalier, L Derré, C Jandus Seminars in immunology 41, 101276, 2019 | 30 | 2019 |
| High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools MF Chevalier, S Bobisse, C Costa-Nunes, V Cesson, P Jichlinski, ... Oncoimmunology 4 (10), e1029702, 2015 | 30 | 2015 |
| Immunoregulation of dendritic cell subsets by inhibitory receptors in urothelial cancer MF Chevalier, P Bohner, C Pieraerts, B Lhermitte, J Gourmaud, A Nobile, ... European urology 71 (6), 854-857, 2017 | 27 | 2017 |
| Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer S Domingos-Pereira, V Cesson, MF Chevalier, L Derré, P Jichlinski, ... Oncoimmunology 6 (1), e1265720, 2017 | 24 | 2017 |
| CD4 T-cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden MF Chevalier, C Didier, PM Girard, ME Manea, P Campa, ... Frontiers in immunology 7, 2016 | 23 | 2016 |
| Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy M Tourret, N Talvard-Balland, M Lambert, GB Youssef, MF Chevalier, ... Journal for Immunotherapy of Cancer 9 (10), 2021 | 21 | 2021 |
| T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection L Weiss, MF Chevalier, L Assoumou, C Didier, PM Girard, C Piketty, ... Aids 28 (11), 1683-1687, 2014 | 21 | 2014 |
Bruce D WalkerDirector, Ragon Institute of MGH, MIT and HarvardE-mail megerősítve itt: mgh.harvard.edu
